TLC BioSciences Corp. (TPEX:7924)

Taiwan · Delayed Price · Currency is TWD

438.50

-43.00 (-8.93%)

At close: Sep 24, 2026

TLC BioSciences Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Equivalents	1,383	694.74	616.41
Short-Term Investments	192.65	-	766.49
Cash & Short-Term Investments	1,575	694.74	1,383
Cash Growth	-	-49.76%	-
Receivables	7.85	20.49	20.38
Inventory	22.72	41.44	61.52
Prepaid Expenses	131.85	165.43	224.69
Other Current Assets	320.49	22.05	32.24
Total Current Assets	2,058	944.15	1,722
Property, Plant & Equipment	589.87	549.37	480.91
Other Intangible Assets	1.24	0.94	1.47
Other Long-Term Assets	52.7	24.18	26.85
Total Assets	2,702	1,519	2,231

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Accounts Payable	-	-	16.21
Current Portion of Long-Term Debt	4.73	879.33	1,245
Current Portion of Leases	19.59	20.11	19.62
Current Unearned Revenue	2.52	2.52	5.12
Other Current Liabilities	11.47	4,214	3,999
Total Current Liabilities	948.75	5,116	5,285
Long-Term Debt	32.32	33.21	39.65
Long-Term Leases	28.96	23.32	15.25
Long-Term Unearned Revenue	23.6	23.56	24.07
Other Long-Term Liabilities	1.8	1.8	4.66
Total Liabilities	1,035	5,198	5,369

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Common Stock	1,336	0.26	0.26
Additional Paid-In Capital	14,954	9,618	9,555
Retained Earnings	-14,586	-13,311	-12,657
Comprehensive Income & Other	-37.18	12.88	-35.84
Total Common Equity	1,666	-3,680	-3,138
Shareholders' Equity	1,666	-3,680	-3,138
Total Liabilities & Equity	2,702	1,519	2,231

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Total Debt	816.73	955.97	1,319
Net Cash (Debt)	758.48	-261.23	63.44
Net Cash Growth	-	-	-
Net Cash Per Share	7.89	-3.14	0.83
Filing Date Shares Outstanding	133.56	83.32	76.69
Total Common Shares Outstanding	133.56	83.32	76.69
Working Capital	1,109	-4,172	-3,563
Book Value Per Share	12.48	-44.16	-40.92
Tangible Book Value	1,665	-3,681	-3,139
Tangible Book Value Per Share	12.47	-44.17	-40.93